| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 11
| Issue : 1 | Page : 81 |
|
|
A retrospective cytogenetic abnormality in pediatric acute lymphoblastic leukemia: Report of 11 years
Kazem Ghaffari1, Athena Kouhfar2, Ali Ghasemi3, Milad Gholami4, Ali Arjmand5, Vahid Falahati2
1 Department of Basic and Laboratory Sciences, Khomein University of Medical Sciences, Khomein, Iran
2 Clinical Research Development Center of Amirkabir Hospital, Arak University of Medical Sciences, Arak, Iran
3 Department of Biochemistry and Hematology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
4 Department of Biochemistry and Genetics, Arak University of Medical Sciences, Arak, Iran
5 Department of Pediatric, Arak University of Medical Sciences, Arak, Iran
Correspondence Address:
Dr. Vahid Falahati
Clinical Research Development Center of Amirkabir Hospital, Arak University of Medical Sciences, Arak
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/abr.abr_103_21
|
|
|
Background: Acute lymphoid leukemia (ALL) is the largest subset of hematologic malignancies, accounting for approximately 70%–80% of childhood leukemia, and is most common at age 4 years. The aim of this study was to define the frequency of chromosomal abnormalities in pediatric ALL.
Materials and Methods: In this 11-year retrospective study, we investigated 99 patients which referred to our department due to ALL from 2010 to 2020. The age group of the patients ranged from 6 months to 14 years with a mean of 6.71 ± 4.09 years. Clinical and diagnostic findings were extracted from patients' medical records.
Results: We showed cytogenetic abnormalities of 99 pediatric ALL patients, including 78 pre-B-ALL, 9 common B-ALL, and 12 T-ALL cases. The 5-year overall survival rate (OSR) and event-free survival (EFS) of all cytogenetic abnormalities (n = 99) were 48% and 43%, respectively. There was a significant relationship between the two cytogenetic abnormalities, hypodiploidy and t(9;22), with death (P < 0.05). On comparing the subjects with normal cytogenetics to the other cytogenetic abnormalities, EFS was significantly low for hypodiploidy (P = 0.0163, hazard ratio = 0.5308) and t(9;22) (P = 0.0131, hazard ratio = 0.4908), while other cytogenetic abnormalities did not have a statistically significant difference in EFS.
Conclusions: Our results emphasized the importance of the cytogenetic findings in evaluating the survival outcomes, which allows identifying a variety of OSR and EFS, because some of the cytogenetic abnormalities may interfere with the death and prognosis.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
